期刊文献+

紫绀型与非紫绀型先天性心脏病对罗库溴铵起效和作用时间的影响 被引量:2

Comparison of pharmocodynamics of rocuronium between congenital heart disease and normal children
下载PDF
导出
摘要 目的 探讨先天性心脏病患儿与正常儿童罗库溴铵药效学的差异,为罗库溴铵在临床小儿心脏手术中的合理应用提供理论依据。方法选择ASAⅡ~Ⅲ,年龄6~12岁先天性心脏痛心内分流患儿30例,分为非紫绀型(n=15)和紫绀型(n=15)两组。另择拟行择期手术的非心脏病患儿15例(对照组)。麻醉诱导后,给予单次剂量罗库溴铵600μg/kg。采用TOF—Watch SX加速度肌松监测仪监测肌松,记录3组患儿患儿罗库溴铵的起效时间、作用时间、恢复状况及相关指标。结果非紫绀组、紫绀组、对照组患儿罗库溴铵的起效时间、临床作用时间、肌松恢复时间和恢复指数分别为(3.2±1.3)min、(22.8±5.1)min、(39.1±3.5)min、(16.4±4.2)min;(4.1±2.5)min、(23.4±3.2)min、(41.0±2.2)min、(17.2±4.5)min和(2.4±1.6)min、(25.3±3.5)min、(40.8±5.0)min、(15.9±1.9)min。3组起效时间的比较有统计学差异(P〈0.05),但三组罗库溴铵的临床作用时间、肌松恢复时间、恢复指数等数据的比较均无统计学意义(P≥0.05)。结论无论紫绀型或非紫绀型先心病心内分流均会延长罗库溴铵的起效时间并可能干扰肌松作用及恢复时间。临床上针对此类病人,应完善肌松监测。 Objective To evaluate the different pharmacodynamic between congenital heart disease and normal children. Methods There were 45 patients aged 6-12 yr involved in the present study, including 15 cases with normal cardiac function, 15 cases with acyanotic congenital heart disease and 15 with cyanotic congenital heart disease. After anesthesia was induced, a bolus dose of rocuronium 600μg/kg was administered to the patients. The onset time, clinic duration and recover time were observed. Results Children with normal cardiac function demonstrated a shorter onset time than children with intracardiac shunts (P〈0.05). There was statistically significant difference between the acyanotic and cyanotic patients (P〈0.05). However, the clinic duration, recover time and recovery index in the 3 group were no statistically significant difference (P〉0. 05). Conclusions These results confirm that the clinical onset of relaxation is delayed and spontaneous recovery may be interfered in children with intracardiac shunts.
出处 《西部医学》 2009年第2期222-224,共3页 Medical Journal of West China
关键词 罗库溴铵 先天性心脏病 肌松监测 Rocuronium Congenital heart disease Monitoring of neuromuscular block
  • 相关文献

参考文献1

  • 1Pinar Zeyneloglu,Asli Donmez,Mesut Sener. Sevoflurane induction in cyanotic and acyanotic children with congenital heart disease[J] 2008,Advances in Therapy(1):1~8

同被引文献14

  • 1杨大烜 ,刘进 ,伍丽明 .紫绀及非紫绀型先天性心脏病患儿罗库溴铵药效学的比较[J].中华麻醉学杂志,2005,25(1):11-14. 被引量:2
  • 2王玉林.先天性心脏病的介入治疗进展[J].实用儿科临床杂志,2005,20(7):612-614. 被引量:22
  • 3Hemmerling TM,Russo G,Bracco D.Neuromuscular blockade in cardiac surgery:an update for clinicians[J].Ann Card Anaesth,2008,11(2):80-90.
  • 4Gueret G,Rossignol B,Kiss G,et al.Is muscle relaxant necessary for cardiac surgery?[J].Anesth Analg,2004,99(5):1330-1333.
  • 5Cammu G,De Baerdemaeker L,Den Blauwen N,et al.Postoperative residual curarization with cisatracurium and rocuronium infusions[J].Eur J Anaesthesiol,2002,19(2):129-134.
  • 6Ouattara A,Richard L,Charriere JM,et al.Use of cisatracurium during fast-track cardiac surgery[J].Br J Anaesth,2001,86(1):130-132.
  • 7Iwasaki H,Igarashi M,Yamauchi M,et al.The effect of cardiac output on the onset of neuromuscular block by vecuronium[J].Anaesthesia,1995,50(4):361-362.
  • 8Minsaas B,Stovner J.Artery-to-muscle onset time for neuromuscular blocking drugs[J].Br J Anaesth,1980,52(4):403-407.
  • 9Kim KS,Cheong MA,Jeon JW,et al.The dose effect of ephedrine on the onset time of vecuronium[J].Anesth Analg,2003,96(4):1042-1046.
  • 10Jellish W S,Brady M,Sawicki K,et al.Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-hased anesthetics[J].Anesth Analg,2000,91(5):1250-1255.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部